baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Goldman Sachs Knock-Out LLY/ DE000GG2ZV92 /

11/10/2024 14:23:43	Chg.+0.49	Bid21:59:48	Ask21:59:48	Underlying	Strike price	Expiration date	Option type
21.49EUR	+2.33%	22.99 Bid Size: 2,000	23.06 Ask Size: 2,000	Eli Lilly and Co	680.549 USD	31/12/2078	Call

TeleTrader 02/10 Eli Lilly to commit $4.5 billion in a new Indiana facility

Newsfile Corp 16/09 Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer

TeleTrader 09/09 Eli Lilly appoints Lucas Montarce as CFO

Newsfile Corp 28/08 The GLP-1 Products and Players - Expanding a new Era of Pharmaceutical Products for Diabetes and Wei...

GlobeNewswire 27/08 Boehringer Ingelheim and Eli Lilly and Company Join American Kidney Fund’s 2024 Corporate Membership...

GlobeNewswire 26/08 Eliem Therapeutics Announces Additions to its Leadership Team

GlobeNewswire 21/08 Atossa Therapeutics and Quantum Leap Healthcare Collaborative Dose First Patient in I-SPY 2 Trial Co...

GlobeNewswire 14/08 Vaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer’s ...

GlobeNewswire 14/08 Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD...

GlobeNewswire 08/08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 08/08 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...

TeleTrader 08/08 US opens higher with data, earnings in focus

GlobeNewswire 08/08 ProQR Announces Second Quarter 2024 Operating and Financial Results

TeleTrader 08/08 Eli Lilly's Q2 revenue jumps 36% to $11.3B

GlobeNewswire 08/08 Defiance Launches LLYX, the First 2X Leveraged Single-Stock ETF on Eli Lilly

GlobeNewswire 07/08 Aclaris Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

GlobeNewswire 06/08 Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Rea...

GlobeNewswire 06/08 SEED Therapeutics (SEED) Enters into Strategic Research Collaboration with Eisai Co., Ltd. to Discov...

GlobeNewswire 02/08 Calling All Morphic Holding, Inc. (MORF) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Cl...

GlobeNewswire 01/08 Merus Announces Financial Results for the Second Quarter 2024 and Provides Business Update

GlobeNewswire 01/08 COUR Pharmaceuticals Announces Leadership Transition for Strategic Growth Objectives

GlobeNewswire 01/08 Compass Pathways announces second quarter 2024 financial results and business highlights

GlobeNewswire 31/07 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFC, HMNF, MORF on Behalf of Shareholders

GlobeNewswire 31/07 MORF Alert: Wohl & Fruchter LLP Files Class Action Lawsuit on Behalf of Shareholders of Morphic Hold...

Goldman Sachs Knock-Out LLY/ DE000GG2ZV92 /

If you wish to receive reply to your feedback, please provide your email address.